Adults with severe growth hormone deficiency will gain access to subsidised somatropin treatment from 1 December 2018. The current PBS listing of somatropin (Genotropin and Genotropin GoQuick) for children has been extended to include eligible adults. It is expected that about 780 patients per year will now be able to access the medicine which would ...
Already a member?
Enter your email to keep reading.